A pharmacist-led, American Heart Association Heart360 web-enabled home blood pressure monitoring program
Source: Circulation: Cardiovascular Quality and Outcomes Area: Evidence> Medicines Management> References Background: To determine whether a pharmacist-led, Heart360-enabled, home blood pressure monitoring (HBPM) intervention improves blood pressure (BP) control compared with usual care (UC). Methods: This randomised, controlled trial was conducted by clinical pharmacy specialists at 10 Kaiser Permanente Colorado clinics. Patients assigned to the HBPM intervention group were provided a properly fitted home BP cuff (Omron HEM-790IT) and were trained on how to use it. Patients were assisted in establishing an account at the Heart360 website and were shown how to automatically upload BPs stored on their home BP device into their Heart360 account. Patients in the HBPM group also met with a clinical pharmacy specialist who reviewed their current BP medication regimen, provided counselling on lifestyle changes, and adjusted or changed antihypertensive medications as needed. Patients were asked to measure their BP at least 3 times per week and to upload ...
CONCLUSION: This multi-departmental approach has facilitated the development of a succinct, systematic guideline for the management of necrotising otitis externa. Initial patient outcomes appear promising. PMID: 32498757 [PubMed - as supplied by publisher]
CONCLUSION: Apparent diffusion coefficient is a non-invasive imaging parameter useful for predicting skull base osteomyelitis in necrotising otitis externa patients. PMID: 32498734 [PubMed - as supplied by publisher]
Publication date: Available online 20 May 2020Source: Journal of Sport and Health ScienceAuthor(s): Tatsuya T. Shigeta, Angus A. Leahy, Jordan J. Smith, Narelle Eather, David R. Lubans, Charles H. Hillman
Publication date: Available online 18 April 2020Source: Journal of Sport and Health ScienceAuthor(s):
Publication date: Available online 6 June 2020Source: Respiratory Physiology &NeurobiologyAuthor(s): Jorge Soliz, Edith M. Schneider-Gasser, Christian Arias-Reyes, Fernanda Aliaga-Raduan, Liliana Poma-Machicao, Gustavo Zubieta-Calleja, Werner I. Furuya, Pedro Trevizan-Baú, Rishi R. Dhingra, Mathias Dutschmann
Publication date: Available online 5 June 2020Source: Respiratory Physiology &NeurobiologyAuthor(s): Daniela Rodrigues Andrade, Kelly Critine Pinto, Julia Sampel de Castro, Daniela Kuguimoto Andaku, Viviani Aparecida Lara, Fabio Augusto de Luca, Carlos Gun, Felipe Augusto Rodrigues Mendes, Mayron F. Oliveira, Wladimir Musetti Medeiros
Publication date: Available online 5 June 2020Source: Respiratory Physiology &NeurobiologyAuthor(s): Alessandra Magini, Mauro Contini, Emanuele Spadafora, Anna Apostolo, Elisabetta Salvioni, Simone Barbieri, Susanna Sciomer, Daniele Andreini, Fabrizio Veglia, Gerald S. Zavorsky, Piergiuseppe Agostoni
Publication date: Available online 6 June 2020Source: Respiratory Medicine Case ReportsAuthor(s): Yusuke Fujibayashi, Hiroyuki Ogawa, Wataru Nishio, Megumi Nishikubo, Yuki Nishioka, Shinya Tane, Yoshitaka Kitamura, Masahiro Yoshimura
CONCLUSION: We present a case of Graves' disease with active, moderate-to-severe Graves' ophthalmopathy in a patient with pre-existing AFTN presenting with a coexisting, rare case of Marine-Lenhart syndrome associated with immune reconstitution after alemtuzumab treatment. PMID: 32500462 [PubMed - as supplied by publisher]
Authors: Kleinaki Z, Kapnisi S, Theodorelou-Charitou SA, Nikas IP, Paschou SA Abstract Diabetes mellitus (DM) is a chronic multisystem disease. Diabetic nephropathy (DN) is one of its significant microvascular complications, associated with increased morbidity and mortality. The aim of this article is to review the literature regarding the latest advances in the management of type 2 DM (T2DM) in patients with chronic kidney disease (CKD). We initially refer to the screening guidelines, the diagnostic tests used, the need for novel biomarkers in DN, the recent advances in high-risk patient identification, the recomm...